Scotia Capital
MBOT icon

Scotia Capital’s Microbot Medical MBOT Stock Holding History

Scotia Capital’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.1K Hold
32,876
– – ﹤0.01% 895
2026
Q1 		$79.2K Buy
32,876
+6,400
+24% +$14.3K ﹤0.01% 891
2025
Q4 		$53K Hold
26,476
– – ﹤0.01% 880
2025
Q3 		$80.8K Buy
26,476
+3,700
+16% +$11.5K ﹤0.01% 883
2025
Q2 		$57.4K Buy
22,776
+1
+0% +$2 ﹤0.01% 844
2025
Q1 		$34.4K Buy
22,775
+9,500
+72% +$16.8K ﹤0.01% 830
2024
Q4 		$14.9K Buy
+13,275
New +$13K ﹤0.01% 847

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Scotia Capital's MBOT Position: Q2 2026 in Review

Scotia Capital held its Microbot Medical (MBOT) position steady in Q2 2026 at 32,876 shares worth $64.1K. The position accounts for ﹤0.01% of the portfolio, ranked #895.

Scotia Capital first reported a position in MBOT in Q4 2024 and has held it in 7 quarters since. The position peaked at $80.8K in Q3 2025. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Scotia Capital held 32,876 shares of Microbot Medical worth $64.1K as of Q2 2026.
  • Scotia Capital left its Microbot Medical share count unchanged in Q2 2026.
  • Microbot Medical made up ﹤0.01% of Scotia Capital's portfolio in Q2 2026, its #895 holding.
  • Scotia Capital first reported a position in Microbot Medical in Q4 2024 and has held it in 7 quarters since.
  • Scotia Capital's Microbot Medical position peaked at $80.8K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.